Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmmerson Regulatory News (EML)

Share Price Information for Emmerson (EML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.95
Bid: 1.90
Ask: 2.00
Change: 0.00 (0.00%)
Spread: 0.10 (5.263%)
Open: 1.95
High: 1.95
Low: 1.95
Prev. Close: 1.95
EML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Phased Development Strategy

15 Apr 2021 07:00

RNS Number : 5636V
Emmerson PLC
15 April 2021
 

 

 

 

 

Emmerson Plc / Ticker: EML / Index: LSE / Sector: Mining

15 April 2021

Emmerson Plc ("Emmerson" or the "Company")

Update on Phased Development Strategy

 

Emmerson plc, the Moroccan focused potash development company, is pleased to provide an important update on the assessment of a conceptual, phased development plan for its 100% owned Khemisset Potash Project ("Khemisset" or "the Project"), aimed at reducing upfront capital costs and incorporating expansion options (RNS dated 17 February 2021).

 

Highlights

· Conceptual, phased development plan completed resulting in major value enhancing opportunities:

o Significantly reduced up-front capex of US$254.6m (pre-contingency)

o Potential for subsequent phases to be funded from internal cash flows

o Estimated NPV8 US$2.37 billion (assuming phase 4 production)

o Forecast EBITDA in first full year of phase 4 production of US$491.4m

· Demonstration of flexibility and additional potential of Khemisset

· Emmerson to continue Project development utilising outputs of this phased approach study

 

Overview

Building on the Feasibility Study ('FS') (refer announcement 1 June 2020), the Company has completed a concept study to examine the potential to develop Khemisset using a four-phased approach to reduce upfront capital costs and execution risk, and plan additional expansion stages to ensure that its economic value is fully developed.

 

The intention of the Company remains to build the full-scale project as identified in the FS, however, the report, undertaken to scoping study levels, identifies the opportunity to commence with a smaller scale start-up operation producing Muriate of Potash ("MOP"), which would be followed by a series of expansion phases to increase the level of MOP produced, and add in the production of de-icing salt in increasing quantities as well as premium potash product, Sulphate of Potash ("SOP").

 

The upfront capex for this strategy, including contingency, is estimated at US$287m. Subsequent phases through to full production would likely be financed from internal cash flows. In full production, the Khemisset Project could produce 800ktpa of MOP, 240ktpa of SOP and 4mtpa of de-icing salt, resulting in an annual EBITDA in the first year of full production of US$491m. This production rate is a significant increase to the existing FS, which the Company believes is justified given the scale and quality of the Khemisset orebody.

 

Key metrics of this phased approach are as follows:

 

Phase 1

Phase 2

Phase 3

Phase 4

Total

MOP Production (t)

350,000

385,000

-

270,000

1,005,000

MOP consumed by SOP production (t)

-

-

(205,000)

-

(205,000)

MOP Sold (t)

350,000

385,000

(205,000)

270,000

800,000

SOP Production (t)

-

-

240,000

-

240,000

De-icing salt (NaCl) Production (t)

-

1,000,000

1,000,000

2,000,000

4,000,000

Capex

(incl. contingency)

US$286.9m

US$140.0m

US$143.7m

US$130.4m

US$701.0m

NPV8

US$518.5m

US$1.06bn

US$1.71bn

US$2.37bn

US$2.37bn

Annual EBITDA

US$63.9m

US$199.1m

US$334.1m

US$491.4m

US$491.4m

 

Graham Clarke, CEO, commented: "This work demonstrates that the Project has the flexibility to be developed in phases, whilst further proving the world class nature of Khemisset. With significant expansion potential that adds huge value to the Project, we are now confident that we could develop Khemisset using a staged approach potentially reducing upfront capital costs and equity requirements from the market and, therefore, dilution to our existing shareholders as we grow to our full potential.

 

"2021 continues to be a pivotal year for Emmerson as we move forward in the development of what is to become the first large scale potash mine in Africa."

 

Further Detail

The aim of the study was to first identify and confirm whether there is the potential for a lower capex phase of development and then to demonstrate that additional development phases could follow which would expand the Project both in terms of product offering and overall capacity.

 

Four phases were identified, the construction requirements assessed, and the associated costs analysed.

 

The first phase focuses on a reduced MOP output stage where the development of the declines and mine would be similar to the FS base case but with a reduced capacity process plant which would result in lower upfront capex. The savings generated are not proportional to the reduction in output as the benefits of scale are not completely captured and the general infrastructure costs remain the same.

 

The second phase expands MOP production to the same level as in the FS with the addition of 1mpta of de-icing salt produced, as in the FS. The additional capex required facilitates the expansion of the process plant capacity along with the salt production plant and additional costs in mine development.

 

Phase three brings in an SOP production facility, expected to be located at the port of Jorf Lasfar, in addition to an increase of de-icing salt production to the level of 2mtpa. The additional capex required is for the construction of the SOP facility and the expansion of the salt production plant.

 

The final phase includes the development of the south-west (SW) area of the resource via two new declines with the ore being transported to the existing process plant which is expanded to increase the capacity to a total of over 1mtpa of MOP a portion of which provides feed into the SOP facility. In addition, this phase sees the further expansion of de-icing salt production to a total of 4mtpa. The additional capex required for this phase covers the establishment of the access and infrastructure for the SW mine and also the expansion of the salt plant to double the capacity to 4mtpa.

 

 

**ENDS**

 

For further information, please visit www.emmersonplc.com, follow us on Twitter (@emmerson_plc), or contact: 

 

Graham Clarke

Edward McDermott

Emmerson plc

+44 (0) 20 7236 1177 

 

Jerry Keen

Toby Gibbs

John More

 

Shore Capital

 

 

+44 (0)20 7408 4090 

Damon Heath

Isabella Pierre

Shard Capital

+44 (0)20 7186 9927

 

Megan Denison

Susie Geliher

 

St Brides Partners Limited

Financial PR/IR

 

+44 (0)20 7236 1177

 

Notes to Editors

Emmerson's primary focus is on developing the Khemisset project ("Khemisset" or the "Project") located in Northern Morocco. The Project has a large JORC Resource Estimate (2012) of 537Mt @ 9.24% K2O and significant exploration potential with an accelerated development pathway targeting a low capex, high margin mine. Khemisset is perfectly located to capitalise on the expected growth of African fertiliser consumption whilst also being located on the doorstep of European markets. This unique positioning means the Project will receive a premium netback price compared to existing potash producers. The need to feed the world's rapidly increasing population is driving demand for potash and Emmerson is well placed to benefit from the opportunities this presents. The Feasibility Study released in June 2020 indicated Khemisset has the potential to be among the lowest capital cost development stage potash projects in the world and also, as a result of its location, one of the highest margin projects. This delivered outstanding economics including a post-tax NPV10 of approximately US$1.4 billion using industry expert, Argus', price forecasts.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEASLSFSEFEEA
Date   Source Headline
31st May 202410:56 amRNSGrant of Share Options and PDMR dealing
31st May 20247:00 amRNSNotice of AGM and Posting of Annual Report
24th May 20247:00 amRNS2023 Financial Results
22nd Apr 202411:47 amRNSTR-1: Notification of major holdings
8th Apr 20244:45 pmRNSResults of Oversubscribed REX Retail Offer
8th Apr 20247:01 amRNSREX Retail Offer
8th Apr 20247:00 amRNSQ1 Update, Equity Placing and Retail Offer
11th Mar 20247:00 amRNSCommittee Upholds Environmental Approval Referral
1st Feb 20247:00 amRNSScoping Study on Breakthrough New Processing Route
8th Jan 20247:00 amRNSQ4 Update
21st Dec 20237:00 amRNSExtension of Mandated Lead Arrangers
26th Sep 20237:00 amRNSInterim Results for the six months to 30 June 2023
21st Sep 20237:00 amRNSQ3 2023 and Financing update
11th Sep 202311:38 amRNSMorocco Statement
11th Jul 202311:57 amRNSDirector/PDMR Shareholding
10th Jul 20234:30 pmRNSDirector/PDMR Shareholding
6th Jul 20232:49 pmRNSDirector/PDMR Shareholding
6th Jul 20237:00 amRNSQ2 Update
6th Jun 20237:00 amRNSExercise & Allotment of Shares
31st May 202312:01 pmRNSResult of AGM
5th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
13th Apr 20237:00 amRNS2022 Financial Results and Q1 Update
14th Feb 20237:00 amRNSMandated Lead Arrangers Appointed for Financing
9th Jan 20237:00 amRNSQ4 Update
3rd Jan 20237:00 amRNSAppointment of Liberum as Nominated Advisor
21st Nov 20227:00 amRNSPotash and Salt Offtake MOUs
27th Sep 20227:00 amRNSDirector/PDMR Shareholding
26th Sep 20221:45 pmRNSResults of REX Retail Offer & Total Voting Rights
26th Sep 20227:02 amRNSREX Retail Offer
26th Sep 20227:01 amRNSRenewal of Strategic Investment & Equity Placing
26th Sep 20227:00 amRNSInterim Results for the six months to 30 June 2022
16th Aug 20224:18 pmRNSExercise of Options & Director/PDMR Shareholding
22nd Jul 20229:00 amRNSShare Options Scheme & Director Shareholdings
19th Jul 20225:05 pmRNSReplacement: Director/PDMR Shareholding
18th Jul 20224:00 pmRNSDirector/PDMR Shareholding
11th Jul 20227:00 amRNSQ2 Activities Update
7th Jul 202212:30 pmRNSResult of AGM
20th Jun 20227:00 amRNSExercise of Warrants and Issue of Shares
13th Jun 20227:00 amRNSNotice of AGM and Posting of Annual Report
31st May 20227:00 amRNSAudited Results for the year ended 31 Dec 2021
31st Mar 20227:00 amRNSQ1 Activities Update
15th Mar 20227:00 amRNSGrant of Share Options
21st Feb 20227:00 amRNSAppointment of Chief Financial Officer
16th Feb 20227:00 amRNSAppointment of Corporate Broker
27th Jan 20227:00 amRNSBasic Engineering Packages Awarded to Reminex S.A
25th Jan 20221:00 pmRNSPart Exercise of Options and Issue of Shares
31st Dec 20217:00 amRNSEnd of Year Newsletter
6th Dec 202112:45 pmRNSResult of AGM
6th Dec 202112:31 pmRNSResult of General Meeting
2nd Dec 20217:00 amRNSOperational Update: Khemisset Potash Project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.